Exploring how psychological stress affects breast cancer treatment outcomes
Official title: The Association of Psychological Stress with the Efficacy of Neoadjuvant Therapy in Breast Cancer
Run by Shengjing Hospital · NCT06690645 · Data updated 2026-11-12
This study looks at how stress and emotions like anxiety and depression might affect how well chemotherapy works for people with breast cancer who are just starting treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 840 (estimated) |
| Sponsor | Shengjing Hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Shenyang, Liaoning) |
| Status | Recruiting |
| Started | November 15, 2024 |
| Main results expected | August 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | November 15, 2024 |
| Trial ID | NCT06690645 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include treatment-naive adults aged 18 and older with a confirmed diagnosis of breast cancer who are about to receive neoadjuvant therapy.
✕Probably not a fit
Patients with concurrent acute or chronic psychiatric disorders or those who have received antidepressant or anti-anxiety therapy within the past month may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the relationship between psychological stress and the effectiveness of neoadjuvant chemotherapy in breast cancer patients. It focuses on treatment-naive individuals who have a confirmed diagnosis of breast cancer and are set to receive standard neoadjuvant therapy. The study aims to assess how factors such as anxiety and depression may influence the therapeutic response, given that emotional distress is prevalent among cancer patients. By understanding these dynamics, the research seeks to shed light on the potential impact of psychological factors on cancer treatment outcomes.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies that consider psychological well-being in breast cancer patients.
How similar studies have gone: While the role of psychological factors in cancer treatment is increasingly recognized, this specific investigation into their association with neoadjuvant therapy efficacy in breast cancer is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1.Age ≥ 18 years; 2.Histological and/or cytological diagnosis of breast cancer; 3.Treatment niave patients; 4.To receive standard neoadjuvant therapy; 5.Eastern Cooperative Oncology Group (ECOG) performance status of 0-1; 6.Presence of at least one measurable lesion according to the Response Evaluation Criteria in Advanced Solid Tumors version 1.1 (RECIST v1.1) ; 7.Informed and agreed to participate in the study; Exclusion Criteria: * 1\. Breast cancer has not been confirmed through histological or cytological examinations. 2.Other breast cancer conditions that do not receive neoadjuvant therapy. 3.Combined with other malignant tumors. 4.Concurrent acute or chronic psychiatric disorders, along with having received antidepressant or anti-anxiety therapy within the past month. 5.Participants must not have engaged in any other clinical trials in the past month, unless those trials are observational or non-interventional in nature.
Where it's running
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China Recruiting
Study contacts
- Study coordinator: Liu Hua, Ph. D
- Email: 20242027@cmu.edu.cn
- Phone: 15140067366
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.